Goldman Sachs upgrades Amgen (AMGN) to Neutral from Sell on the heels of the biotech concern's...

|About: Amgen Inc. (AMGN)|By:, SA News Editor

Goldman Sachs upgrades Amgen (AMGN) to Neutral from Sell on the heels of the biotech concern's change in management. Analysts with the firm have been calling for a "new strategic direction" for AMGN for quite a while.